Live Breaking News & Updates on Translational Research Committee

Stay updated with breaking news from Translational research committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PanCAN Welcomes New Leadership to Scientific & Medical Advisory Board- Pancreatic Cancer Action Network

PanCAN’s Scientific & Medical Advisory Board (SMAB) welcomes new leadership and members, representing the foremost expertise in the field of pancreatic cancer from institutions across the US. ....

United States , Dana Farber Cancer Institute , E Gabriela Chiorean , Julie Fleshman , Andrew Hendifar , Jason Fleming , Jenniferb Permuth , Efrat Dotan , Mike Pishvaian , Anirban Maitra , Hedy Kindler , Georgea Fisher Jr , Eileenm Oreilly , Gregory Beatty , Jen Yeh , Margaret Tempero , Peter Hosein , Marcuss Noel , Jonathan Brody , Leslie Gaynor , Sapna Syngal , Aatur Singhi , Phyllis Bolotin , Colin Weekes , Fox Chase Cancer Center , Pancreatic Cancer Research ,

The Pancreatic Cancer Action Network (PanCAN) Announces New Scientific and Medical Advisory Board Leaders and Members

Nonprofit’s Scientific and Medical Advisory Board Represented by Foremost Leaders in Pancreatic Cancer Field LOS ANGELES, Calif. – (July 18, [.] READ MORE ....

United States , Dana Farber Cancer Institute , Mike Pishvaian , Anirban Maitra , Efrat Dotan , Eileenm Oreilly , Georgea Fisher Jr , Andrew Hendifar , Julie Fleshman , Marcus Noel , Jason Fleming , Jennifer Permuth , Aatur Singhi , Colin Weekes , Hedy Kindler , Sapna Syngal , Jonathan Brody , Gregory Beatty , Jen Yeh , Peter Hosein , Perelman School Of Medicine , Moffitt Cancer Center , Pancan Precision Promise Steering Committee , Pancreatic Cancer Research , Davidm Rubenstein Center , Fox Chase Cancer Center ,

THE PANCREATIC CANCER ACTION NETWORK (PANCAN) ANNOUNCES NEW SCIENTIFIC AND MEDICAL ADVISORY BOARD LEADERS AND MEMBERS

/PRNewswire/ The Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in the fight against pancreatic cancer, proudly announces the addition of. ....

Dana Farber Cancer Institute , United States , Aatur Singhi , Hedy Kindler , Colin Weekes , Jen Yeh , Andrew Hendifar , Jonathan Brody , Eileenm Oreilly , Efrat Dotan , Marcus Noel , Peter Hosein , Jillian Scholten , Julie Fleshman , Jennifer Permuth , Jason Fleming , Sapna Syngal , Mike Pishvaian , Gregory Beatty , Anirban Maitra , Georgea Fisher , Temple Health , University Of Washington Fred Hutchinson Cancer Center , University Of Miami , Pancan Precision Promise Steering Committee , Medstar Georgetown University Hospital ,

Leap Therapeutics Announces Appointment of Richard L. Schilsky, MD to its Board of Directors

/PRNewswire/ Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today. ....

United Kingdom , United States , New Zealand , Matthew Deyoung , Christopher Mirabelli , Douglase Onsi , Richardl Schilsky , American Society Of Clinical Oncology , National Cancer Institute , University Of Chicago Pritzker School Medicine , Dean For Clinical Research , University Of Chicago , Leap Therapeutics Inc , Department Of Medicine , Translational Research Committee , Leukemia Group , Drug Administration , Sciences Division , Beigene Ltd , Oncologic Drugs Advisory Committee , Securities Exchange , University Of Pennsylvania , University Of Chicago Cancer Research Center , Leap Therapeutics , Leap Therapeutic , Drugs Advisory ,

Scandion Oncology engages former ASCO executive as clinical advisor

Scandion Oncology engages former ASCO executive as clinical advisor
Scandion Oncology is pleased to announce that we have appointed Dr. Richard L. Schilsky, a seasoned and highly profiled international leader as a member of our clinical advisory board (CAB). Dr. Schilsky is the former CMO and Executive Vice President of the American Society of Clinical Oncology (ASCO) and a long-time faculty member of the University of Chicago.
Scandion Oncology A/S
Publicerad: 21 april 2021, 11:30
Copenhagen, April 21, 2021. Scandion Oncology, The Cancer Drug Resistance Company, is pleased to announce that
Richard L. Schilsky, MD, FACP, FSCT, FASCO has accepted to join the clinical advisory board of Scandion Oncology. ....

Richard Schilsky , Peter Michael Vestlev , Richardl Schilsky , European Organization For Research , Drug Administration , Sciences Division , Cancer Drug Resistance Company , Dean For Clinical Research , Udall Foundation , Oncologic Drugs Advisory Committee , University Of Chicago , University Of Chicago Cancer Research Center , Friends Of Cancer Research , Department Of Medicine , Translational Research Committee , Scandion Oncology , Scientific Advisors , Michael Vestlev , Professor Emeritus , Executive Vice President , Conquer Cancer , Chicago Cancer Research Center , Associate Dean , Clinical Research , Biological Sciences Division , Cancer Research ,